ADAM-12 stability in first trimester maternal serum

被引:8
作者
Cowans, N. J. [1 ]
Stamatopoulou, A. [1 ]
Jaakohuhta, S. [2 ]
Spencer, K. [1 ]
机构
[1] King George Hosp, Prenatal Res Unit, Dept Clin Biochem, Goodmayes IG3 8YB, England
[2] PerkinElmer, Turku, Finland
关键词
ADAM-12; screening; stability; first trimester; T21; aneuploidy; POTENTIAL MARKER; 2ND TRIMESTER; ADAM12; LEVELS; PAPP-A; 1ST-TRIMESTER; METALLOPROTEASE; 2ND-TRIMESTER; DISINTEGRIN; PREGNANCIES; TRISOMY-21;
D O I
10.1002/pd.2522
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Maternal serum A Disintergrin And Metaloprotease-12 (ADAM-12) has been proposed as a marker for prenatal screening of chromosomal abnormalities, pre-eclampsia and other adverse pregnancy outcomes. In this study, we examine the stability of ADAM-12 with time and at different temperatures. Methods Maternal serum and whole blood pools were stored at 30 degrees C, room temperature and refrigerator temperature or subjected to repeated freeze thaw cycles. ADAM-12 was measured at set time points using an automated DELFIAO (R) research assay. Results Using a 10% change in concentration as a limit of stability, ADAM-12 is stable in serum for less than 15 h at 30 degrees C, less than 20 h at room temperature and for 51 h at refrigerator temperature. ADAM-12 levels are not altered following three -20 degrees C to room temperature freeze-thaw cycles. The stability of ADAM-12 in whole blood appears similar to that in serum. Conclusions The findings of this study suggest that ADAM-12 may be unstable under many routine laboratory conditions, and the marker's instability may also be partly responsible for the discrepancies in the literature. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 28 条
[1]  
ANDERSON G, 1991, CLIN CHEM, V37, P398
[2]   ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome [J].
Christiansen, Michael ;
Spencer, Kevin ;
Laigaard, Jennie ;
Cowans, Nicholas J. ;
Larsen, Severin Olesen ;
Wewer, Ulla M. .
PRENATAL DIAGNOSIS, 2007, 27 (07) :611-615
[3]   ADAM 12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome [J].
Christiansen, Michael ;
Pihl, Kasper ;
Hedley, Paula L. ;
Gjerris, Anne-Cathrine ;
Lind, Pia O. ;
Larsen, Severin Olesen ;
Krebs, Lone ;
Larsen, Torben .
PRENATAL DIAGNOSIS, 2010, 30 (02) :110-114
[4]   First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system [J].
Cowans, Nicholas J. ;
Spencer, Kevin .
PRENATAL DIAGNOSIS, 2007, 27 (03) :264-271
[5]  
COWANS NJ, 2009, PAPP A FREE BETA HCG
[6]   Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies [J].
Donalson, Kim ;
Turner, Steve ;
Wastell, Hilary ;
Cuckle, Howard .
PRENATAL DIAGNOSIS, 2008, 28 (10) :904-907
[7]   A novel, secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo [J].
Gilpin, BJ ;
Loechel, F ;
Mattei, MG ;
Engvall, E ;
Albrechtsen, R ;
Wewer, UM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :157-166
[8]   Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia [J].
Laigaard, J ;
Sorensen, T ;
Placing, S ;
Holck, P ;
Fröhlich, C ;
Wojdemann, KR ;
Sundberg, K ;
Shalmi, AC ;
Tabor, A ;
Norgaard-Pedersen, B ;
Ottesen, B ;
Christiansen, M ;
Wewer, UM .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :144-149
[9]   The level of ADAM12-S in maternal serum is an early first-trimester marker of fetal trisomy 18 [J].
Laigaard, J ;
Christiansen, M ;
Fröhlich, C ;
Pedersen, BN ;
Ottesen, B ;
Wewer, UM .
PRENATAL DIAGNOSIS, 2005, 25 (01) :45-46
[10]   ADAM12:: a novel first-trimester maternal serum marker for Down syndrome [J].
Laigaard, J ;
Sorensen, T ;
Fröhlich, C ;
Pedersen, BN ;
Christiansen, M ;
Schiott, K ;
Uldbjerg, N ;
Albrechtsen, R ;
Clausen, HV ;
Ottesen, B ;
Wewer, UM .
PRENATAL DIAGNOSIS, 2003, 23 (13) :1086-1091